Trials / Withdrawn
WithdrawnNCT02590380
Comparing Pedicle Screw Systems for the Treatment of Adolescent Paediatric Spine Deformity
A Randomized Controlled Trial: Comparison of a Top Loading MESA® Spinal System With MESA Rail™ and a Side Locking Pedicle Screw System for the Treatment of Adolescent Paediatric Spine Deformity
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- K2M, Inc. · Industry
- Sex
- All
- Age
- 11 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system.
Detailed description
Evaluation of the efficacy of the K2M MESA Rail™ Deformity System at improving coronal and sagittal correction of the adolescent idiopathic spine deformity in comparison to the side loading DePuy Synthes USS II pedicle screw system. This is a single-center, single-surgeon randomized controlled trial with follow-up evaluations of patients conducted at initial follow-up (2 weeks to 8 weeks), 3 months, 12 months and 24 months post-procedure. Adverse events will be monitored continuously.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MESA Rail Deformity System | The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the MESA Rail Deformity System. |
| DEVICE | DePuy Synthes USS II System | The spinal deformity will be correction via a standard of care procedure performed by the principal investigator. The correction will be fixated with the DePuy Synthes USS II system. |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2028-09-01
- Completion
- 2030-09-01
- First posted
- 2015-10-29
- Last updated
- 2021-10-21
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02590380. Inclusion in this directory is not an endorsement.